Replies to post #79780 on Cytodyn Inc (CYDY)

[hopester]

Probably go up.

But will it be approved or delayed with FDA further questions?
When will it be approved if it is? How long from now?
From what px level will it be before it does get the assumed approval?
It's possible the px will fall before then.
Will they run out of cash before then?

[Black-Ops]

Long side answer.
You asked about the CYDY Common share price with one catalyst, the FDA Approval for HIV.

There is a mountain of ifs and what ifs in-between that coming event which is in December by my best guess.

I will lay some ground work. Lets stipulate Leron works as well in the current Covid-19 trial as it did in a small Trial. That seems to be an easy stipulation.

I assume the FDA knows who is receiving Leron and who isn't. Joe's mother is receiving it and Sally's mother gets the sugar pill. The FDA could have offered me 1 million a year to play God and I wouldn't take the job. One Mother dies the other lives.

I'm betting the results are spectacular. The FDA opens it up to all in the test. Humanitarian use. It is also possible an early approval hits.

That's a lot of betting and ifs.

IF we receive full Covid-19 FDA approval our share price sure will not be 3$

WE are still pre revenue to that exact point in time. Share price might soar to 10$, might soar to 20$ Might hit 25$ as shorts are bought in by the broker and the broker hits their client with liens for the negative equity in their short account. Then the stock subsides to 20$ after most shorts were destroyed.

Nader can do a half Billion 500,000,000$$ underwriting.

Remember we have limitations on available outstanding shares compared to authorized.

That is not a road block. It's a bump in the road. A small delay. Any Investment Banker knows how to Remedy that issue. I know how.

Now time ticks on and we approach the next catalyst; HIV.

It hits. If the stock was 5$ to 20$ now it's 30$ maybe 40$, 50$

Were in the wild west of breaking news.

Why? I hear. Covid-19 is a big $$ in revs for us but HIV is huge in comparison.
Run your own numbers for earnings potentials. Depending on how Nader sets up a sales team, if at all because he may opt to split revenues with a Drug company with a sales force but needs a product.

I can paint a picture that for every billion $$ in revs we increase our earnings by 1$ per share. I'm using 700,000,000 share as current outstanding and I know its less than that number.

In the 1970s I called the thought above as the Big Picture. Paint your own Big Picture , run the numbers and guess 100 plus PE Ratio because I believe Leron is the start of a Medical Revolution, a Franchise.

Companies are valued on their ability to earn $$. Period